Regulatory Update: Standardized Sleep Protocol as a Postoperative Care Bundle for Cardiac Surgery Patients

This report covers a planned standardized sleep protocol for adults undergoing cardiac surgery, its regulatory framing, sponsor information, and implications for postoperative care.

Date: February 15, 2026. A new standardized sleep protocol for adults undergoing cardiac surgery is advancing toward evaluation as a care bundle. The trial compares the Standardized Sleep Protocol with Usual Postoperative Care to assess feasibility and patient safety during recovery. The project is sponsored by Horizon Health Network and the New Brunswick Heart Centre and is not yet recruiting. The public record can be accessed on ClinicalTrials.gov at the link below.

In this article: What changed? How is the study designed? What is the regulatory context? What safety and ethics notes apply? FAQ

What changed in sleep management for cardiac surgery patients?

The study introduces a Standardized Sleep Protocol as a care bundle to guide sleep related care after cardiac surgery. The intervention aims to standardize environmental factors and care routines that influence restorative sleep during the postoperative period. The control condition is Usual Postoperative Care, which serves as the comparator. The record lists the intervention as Other: Standardized Sleep Protocol and the control as Other: Usual Post Operative Care, signaling a bundle oriented approach rather than a drug or device trial. Sponsors Horizon Health Network and the New Brunswick Heart Centre support the work, and the status is Not yet recruiting. The ClinicalTrials.gov record provides a public reference to the trial and helps ensure transparency for clinicians and researchers interested in sleep optimization after surgery. For more context you can view the study record at ClinicalTrials.gov.

How is the study designed and who funds it?

The public record presents a comparative design between a standardized sleep protocol and usual postoperative care. While the exact randomization and blinding details are not stated in the excerpt, the description emphasizes a care bundle approach rather than a discrete device. The study is funded by Horizon Health Network in collaboration with the New Brunswick Heart Centre. The status is Not yet recruiting, indicating that enrollment has not started yet and that the trial plan is under regulatory and institutional review. This setup aligns with how care based interventions are documented in trial registries to inform clinicians and regulators about potential improvements in postoperative recovery.

What is the regulatory framing for this sleep protocol as a care bundle?

From a regulatory standpoint the record follows a pattern used for therapy related investigations where a care concept is tested as a bundle. The MDR style guidance referenced in related documentation prompts discussion of intended use, performance expectations, and safety considerations for device like interventions. However the public record itself does not declare the sleep protocol as a medical device and does not provide device level performance data. That distinction matters for regulatory classification and for risk management planning. In this article we describe the approach as a care oriented intervention that may raise regulatory questions about labeling, monitoring, and post market oversight if considered a device in future steps. The link to the public record remains the primary source for regulatory context: ClinicalTrials.gov.

What safety and ethics notes apply?

While the trial status is not recruiting yet, standard safety measures for postoperative research would apply. These include ethics committee review, informed consent, data monitoring for sleep related outcomes, and oversight of any adverse events during the recovery period. The article signals a commitment to transparency by referencing the official trial record and sponsor organizations. Stakeholders should monitor updates from ClinicalTrials.gov and from Horizon Health Network for any published results or amendments to the protocol.

What are the milestones and status?

At this stage the trial is not yet recruiting and no results are available. Milestones would typically include approval by the ethics committee, site activation, patient enrollment, data collection, and publication of outcomes. Readers should track the ClinicalTrials.gov page for the most current status and for any protocol amendments that may influence the interpretation of subsequent results.

FAQ

  1. 1. What is the Standardized Sleep Protocol?
    A care bundle described as a standard approach to support sleep during the recovery after cardiac surgery, used as an intervention in the trial.
  2. 2. Who sponsors the trial?
    Horizon Health Network and the New Brunswick Heart Centre are listed as sponsors.
  3. 3. What does Not yet recruiting mean?
    It means enrollment has not started yet and the study is preparing for regulatory and ethical review.
  4. 4. Where can I find the official trial record?
    The record is available on ClinicalTrials.gov at the link provided in the article.

Conclusion and implications for readers

The introduction of a standardized sleep protocol as a postoperative care bundle signals a shift toward structured sleep management in the cardiac surgery setting. Regulators and clinical teams will watch for definitions of intended use, safety data, and performance indicators that determine the potential to scale. The current status not yet recruiting indicates that clinical results are not yet available, but the registry provides a pathway for future dissemination and accountability. Stakeholders such as hospital administrators, surgeons, anesthesiologists, nursing leaders, and patients may all benefit from transparent updates as the trial progresses.

Disclaimer

This information is intended for healthcare professionals and researchers. It is not legal advice and does not replace regulatory guidance from authorities. For formal regulatory interpretation please consult the MDR and national regulations applicable in your jurisdiction.

For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07401836?term=medical+device
Scroll to Top